LNS-Zn0 | LNS-Zn5 | LNS-Zn10 | LNS-TabZn5 | P-value among 4 intervention groupsa,b | IC | NIC | P-value between cohortsa,b | ICCc | DEd | |
---|---|---|---|---|---|---|---|---|---|---|
Plasma zinc concentration (μg/dL)e | ||||||||||
N (9 and 18 mo) | 84 | 74 | 79 | 73 | 310 | 93 | ||||
Unadjusted pZC at 9 months | 66.2 (63.4, 69.0) | 66.0 (63.5, 68.6) | 68.9 (66.5, 71.3) | 68.8 (65.8, 72.0) | 0.255 | 67.4 (66.1, 68.8) | 65.1 (62.5, 67.7) | 0.078 | 0.00 | 1.0 |
Adjusted pZC at 9 months | 68.0 (65.2, 70.9) | 68.1 (65.6, 70.8) | 71.0 (68.6, 73.5) | 71.2 (68.1, 74.5) | 0.212 | 69.5 (68.2, 70.9) | 67.1 (64.5, 69.9) | 0.090 | 0.00 | 1.0 |
Unadjusted pZC at 18 months | 61.7 (59.2, 64.4) | 62.5 (60.1, 65.0) | 64.4 (61.9, 67.0) | 64.5 (62.4, 66.6) | 0.774 | 63.2 (62.0, 64.4) | 61.6 (59.4, 63.8) | 0.968 | 0.02 | 1.3 |
Adjusted pZC at 18 months | 63.3 (60.7, 65.9) | 64.2 (61.8, 66.7) | 66.0 (63.5, 68.7) | 65.9 (63.8, 68.1) | 0.742 | 64.8 (63.6, 66.0) | 63.6 (61.4, 65.8) | 0.831 | 0.03 | 1.4 |
Change in adjusted pZCf | −4.9 (−6.93, −2.78) | −4.0 (−6.58, −1.41) | −4.8 (−7.46, −2.13) | −6.0 (−8.89, −3.05) | 0.843 | −4.9 (−6.16, −3.64) | −3.9 (−6.23, −1.51) | 0.391 | – | – |
% Low plasma zinc concentration (pZC <65 μg/dL)e | ||||||||||
Low unadjusted pZC at 9 months, N (%) | 38 (45.3) | 34 (45.9) | 28 (35.4) | 33 (45.2) | 0.498 | 133 (42.9) | 44 (47.3) | 0.399 | – | – |
Low adjusted pZC at 9 months, N (%) | 29 (34.5) | 28 (37.8) | 22 (27.8) | 27 (37.0) | 0.587 | 106 (34.2) | 36 (38.7) | 0.370 | – | – |
Low unadjusted pZC at 18 months, N (%) | 53 (63.1) | 46 (62.2) | 46 (58.2) | 39 (53.4) | 0.909 | 184 (59.3) | 56 (60.2) | 0.379 | – | – |
Low adjusted pZC at 18 months, N (%) | 50 (59.5) | 42 (56.8) | 43 (54.4) | 34 (46.6) | 0.723 | 169 (54.5) | 51 (54.8) | 0.425 | – | – |